Navigation Links
CEA in Medical News

Micromet, Inc. Reports Second Quarter 2009 Financial Results

...al product pipeline includes several novel BiTE antibodies generated with its proprietary BiTE antibody platform technology. A BiTE antibody targeting cea for the treatment of solid tumors is being developed in collaboration with MedImmune. In addition, Micromet has entered into an option, collaboration ...

Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203

...al product pipeline includes several novel BiTE antibodies generated with its proprietary BiTE antibody platform technology. A BiTE antibody targeting cea for the treatment of solid tumors is being developed in collaboration with MedImmune. In addition, Micromet has entered into an option, collaboration ...

Defeating nicotine's double role in lung cancer

...te for Research, Hospitalization and Health Care (IRCCS), Catholic University, Campus Biomedico University in Rome, Mario Negri Institute in Milan and cea Gyf sur Yvette in France showed in past research that an antagonist of nicotine acetylcholine receptors (nAChRs), may serve as an anticancer agent. Th...

VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque

...linical trials, including without limitation, with respect to the safety and efficacy of VIA-2291; -- if the results of the ACS and cea studies, upon further review and analysis, are revised or negated by authorities or by later stage clinical trials; -- o...

Measles virus may be effective prostate cancer treatment

...an excellent safety record with millions of vaccine doses having been safely administered in over 40 years of use. Repeated measurements of the marker cea (carcinoembryonic antigen, produced when the virus replicates) following MV-CEA treatment can be performed via a simple blood test, and can potentiall...

AdvaMed 2008 Sponsor Participation Increases by 52%

...nt Track) -- Powell Goldstein LLP (Emerging Company Issues Track) -- REED Exhibitions (Global Business Issues Track) Collateral Sponsors: -- cea Technologies -- Ernst & Young -- Georgia Hidden List Department of Economic Development -- Korn/Ferry International -- MedNet Solut...

Micromet, Inc. Reports Second Quarter 2008 Financial Results

..., Inc. and is being developed in a phase 1 clinical trial for the treatment of patients with cancer. Three additional BiTE antibodies, targeting CD33, cea and MCSP, respectively, are in preclinical development. In addition, Micromet has established a collaboration with Nycomed for the development and com...

FDA Grants AMDL Clearance to Market the AMDL-ELISA DR-70(R) (FDP) Blood Test for Monitoring Colorectal Cancer

...et that the FDA has granted for any monitoring product for CRC since January 14, 1982 when Carcinoembryonic Antigen (CEA) was approved. Until now, the cea test has been the only accepted method cleared in the U.S. DR-70 (FDP) offers a new test that can monitor CRC tumors post-surgery. The DR-70 (FDP) t...

Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals

...y determination services to America's hospitals. cea guides uninsured patients through complex applicat...Led by Ulrich and his exceptional management team, cea provides tremendous value to its hospital customer...s across the country. We are quite excited to help cea continue its impressive growth, and we look forwar...

Partnerships Effective Communicators of Cancer Advances

...planning. Nearly all the patients (93 percent) received appropriate surveillance with history and physical exams at suggested intervals and routine cea testing. Abdominal and pelvic surveillance CT was performed in 78 percent of patients. "We found a drop-off in compliance (49 percent) regarding th...

Partnership of academic centers and community hospitals effective model for disseminating advances

...eport (91 percent), colonoscopy (75 percent and 58 percent reaching cecum), cea (91 percent), CT abdomen/pelvis (93 percent), and chest imaging (100 percen...eillance with history and physical exams at suggested intervals and routine cea testing. Abdominal and pelvic surveillance CT was performed in 78 percent o...

Vascular surgeons ask, what's next for carotid artery stenting?

... of Vascular Surgery. "Currently, the choice of cea versus CAS in individual patients is based more on... has now been fairly well established that CAS and cea yield comparable results in "high-risk" patients. ...isk" patients. Some studies suggest that CAS and cea produce similar results, but others have found a l...

Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients

...cromet's proprietary BiTE product development platform. In addition to current studies of MT103, three other BiTE antibodies, targeting EpCAM (CD326), cea and MCSP, are in pre-clinical development. BiTE is a registered trademark of Micromet. About MT103 MT103, which is being co-developed with MedIm...

Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action

...oof-of-concept in an ongoing phase 1 clinical study in advanced non-Hodgkin's lymphoma patients. Three other BiTE antibodies, targeting EpCAM (CD326), cea and MCSP, are in pre-clinical development. About Micromet, Inc. (http://www.micromet-inc.com ) Micromet, Inc. is a biopharmaceutical company develo...

Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia

...oof-of-concept in an ongoing phase 1 clinical study in advanced non-Hodgkin's lymphoma patients. Three other BiTE antibodies, targeting EpCAM (CD326), cea and MCSP, are in pre-clinical development. About MT103 (MEDI-538) MT103, which is being co-developed with MedImmune as MEDI-538, is a BiTE(R) antibo...

18F-DG PET/CT can highly increase the detection of colorectal cancer

...2006. After PET/CT imaging, recurrence and/or metastasis were confirmed in 82.4% (56/68) of the patients, with 91.7% (22/24) cases with elevated serum cea levels. PET/CT detected more lesions than CT or ultrasonography alone in 30.4 % (17/56) of the cases of recurrence and/or metastasis. CRC is the m...
Other Tags
(Date:3/19/2015)... Conn. , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, announces ... in a news clip that aired this week on ... ) . In a segment "The Next Great ... wallet ,a new way to pay, and ,a really big ...
(Date:3/17/2015)... 17, 2015 MedNet Solutions , ... clinical study management systems, is pleased to announce ... ARENA,s Outsourcing in Clinical Trials Southeast conference – ... an excellent forum for MedNet to showcase ... software-as-a-service (SaaS) eClinical technology platform. We ...
(Date:3/17/2015)... 2015  MecklerMedia Corporation (OTCQX: MECK) announced its ... robots ever held in New York ... 11-13, 2015 at the Javits Convention Center. ... include: Acorn Product Development; Axis NJ; c-Link Systems; ... Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
(Date:3/27/2015)... Top medical tourism firm, VisitandCare.com ... the Dominican Republic to benefit from the experience of ... the medical tourism industry upside-down and becoming a choice ... services becoming the central influence. , “Trust is ... are not only attracted to low-cost surgical enhancement, but ...
(Date:3/27/2015)... Dallas, TX (PRWEB) March 27, 2015 ... Landscape – Germany” is an essential source of ... and reimbursement landscape in Germany. Germany’s increasingly elderly ... drivers of its pharmaceutical market. In 2013, the ... expected to increase at Compound Annual Growth Rate ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 DrugDev announced ... (Liss) Easy was named to the 2015 Philadelphia Business ... 40 list spotlights 40 dynamic, up-and-coming leaders less than ... community involvement. Winners are honored at an awards program ... the Philadelphia Business Journal. , Lyn Kremer, Publisher of ...
(Date:3/27/2015)... According to Health Day , ... Neonatal Abstinence Syndrome (NAS) are causing alarm for Florida ... withdrawal process for a month of their lives- and ... and vomiting. The condition is precipitated by drug use ... treatment (and employing medically assisted drug treatment) will also ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 California’s ongoing ... blizzards in Boston and the United States Northeast, are ... Earth warming global atmosphere is creating changes in the ... historical climatologist and former NASA researcher, speaking on the ... result is not only a warmer and dryer global ...
Breaking Medicine News(10 mins):Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 2Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 3Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 4Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3
Other Contents